Results are estimates only — consult your healthcare provider before making medical decisions.

Ozempic at a Glance

~15%
Average weight loss (STEP-1, 68 weeks)
2.0 mg
Maximum weekly dose
$900/mo
Retail price without insurance
$25/mo
With commercial insurance + savings card

What Is Ozempic? FDA-Approved Indications

Ozempic is the brand name for semaglutide, a weekly injectable GLP-1 receptor agonist manufactured by Novo Nordisk. It was first approved by the FDA in December 2017.

FDA-approved indications for Ozempic:

  • Improve blood sugar control in adults with Type 2 diabetes as an adjunct to diet and exercise
  • Reduce the risk of major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with Type 2 diabetes and established cardiovascular disease (LEADER trial data)
  • Reduce cardiovascular risk in adults with overweight or obesity and established cardiovascular disease, regardless of diabetes status (SELECT trial, approved December 2023)

Ozempic is not FDA-approved specifically for chronic weight management in people without diabetes — that is the indication for Wegovy (semaglutide 2.4mg). Many physicians prescribe Ozempic off-label for weight loss in non-diabetic patients, particularly when Wegovy is unavailable or not covered.

Ozempic Weight Loss Data: What the STEP-1 Trial Shows

The most cited clinical evidence for semaglutide's weight loss effects comes from the STEP-1 trial (Wilding et al., NEJM, 2021). Note that STEP-1 used semaglutide 2.4mg (Wegovy's dose) — Ozempic's maximum approved dose is 2.0mg, so real-world Ozempic results may be slightly lower.

TimepointAverage Weight Lost (%)Average Weight Lost (lbs, 220 lb person)% Patients Achieving This Level
3 months~6%~13 lbs~75%
6 months~10%~22 lbs~60%
12 months~13%~29 lbs~50%
68 weeks (~16 months)~14.9%~33 lbs100% (trial endpoint)

Data from STEP-1 trial (semaglutide 2.4mg). Individual results vary significantly based on diet, exercise, adherence, starting weight, and dosage. These are population averages.

Get your personalized weight loss prediction based on your starting weight and medication:

Use the Weight Loss Calculator →

Ozempic Dosing Schedule: Complete Titration Guide

Ozempic uses a gradual dose escalation protocol designed to minimize gastrointestinal side effects while allowing your body to adjust to the medication. Never accelerate the titration schedule — doing so increases nausea and vomiting risk without improving weight loss outcomes.

PhaseDurationDosePurpose
InitiationWeeks 1–40.25 mg/weekTolerance building — not therapeutic
Escalation 1Weeks 5–80.5 mg/weekFirst therapeutic dose
Escalation 2Weeks 9–121.0 mg/weekStandard maintenance for many patients
Maximum DoseWeek 13+2.0 mg/weekMaximum approved dose; not all patients reach this

Many providers slow titration for patients with sensitivity, spending 8 weeks (rather than 4) at each dose level. This is clinically appropriate and does not reduce the ultimate weight loss achieved.

Injection technique: Ozempic is injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm. Rotate injection sites weekly. Inject on the same day each week. The pen can be stored at room temperature (up to 77°F) for up to 56 days after first use.

Ozempic Cost: 2026 Pricing Breakdown

Payment MethodMonthly CostAnnual CostNotes
No insurance (retail)~$900~$10,800List price varies by pharmacy
Commercial insurance$25–$75$300–$900Requires prior authorization for diabetes indication
Medicare Part D~$35~$420 Covered for Type 2 diabetes; IRA caps OOP at $2,000/year
Medicaid$0–$10$0–$120Coverage and eligibility vary by state
Novo Nordisk savings cardAs low as $25$300 Commercially insured patients; not eligible with Medicare/Medicaid
Compounded semaglutide$150–$300$1,800–$3,600From PCAB-accredited pharmacies; not FDA-approved

Find the cheapest Ozempic payment option for your situation:

Use the Cost Calculator →

Ozempic Side Effects

The most common Ozempic side effects are gastrointestinal, caused by the medication slowing gastric emptying. These are most pronounced during dose escalation and typically improve significantly after 4–8 weeks at each dose level.

  • Nausea (40–50%): Most common complaint. Eat smaller portions, eat slowly, prioritize protein and avoid high-fat meals. Taking the injection before bedtime may help some patients.
  • Vomiting (10–20%): If vomiting is severe or persistent, contact your doctor — dose reduction or slower titration may be appropriate.
  • Diarrhea (15–25%): Usually self-limiting. Stay well-hydrated. Consider probiotic supplementation.
  • Constipation (10–15%): Often follows the initial nausea phase. Increase fiber and fluid intake.
  • Decreased appetite: A desired effect, but ensure you still meet protein minimums to prevent muscle loss.
  • Injection site reactions (5%): Mild redness or itching at injection site. Rotate sites regularly.

Serious but rare risks include pancreatitis, gallbladder disease, and medullary thyroid carcinoma (black box warning). Ozempic is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Protein Needs on Ozempic: Protecting Your Muscle Mass

One of the most important — and often overlooked — aspects of Ozempic therapy is maintaining adequate protein intake. Because Ozempic dramatically reduces appetite, many users inadvertently consume far too little protein, leading to significant muscle loss alongside fat loss.

The Obesity Medicine Association recommends GLP-1 users consume 1.2–1.6 grams of protein per kilogram of body weight daily. For someone weighing 200 lbs (91 kg), that means 109–145 grams of protein per day — significantly more than the standard 0.8 g/kg recommendation.

Key protein strategies for Ozempic users:

  • Eat protein first at every meal. Ozempic causes early satiety — if you fill up on carbs first, you won't have room for protein.
  • Use liquid protein sources on high-nausea days. Greek yogurt, protein shakes, and cottage cheese are easier to get down than solid meat.
  • Prioritize resistance training. Even 2x per week significantly reduces the proportion of lean mass lost during GLP-1-assisted weight loss.

Calculate your exact daily protein target based on your weight and activity level:

Use the Protein Calculator →

Frequently Asked Questions About Ozempic

How much weight can you lose on Ozempic in 3 months?

Based on STEP-1 trial data, the average weight loss at 3 months is approximately 6% of starting body weight. For a 220-pound person, that's roughly 13 pounds. Some patients lose significantly more; others lose less. The fastest loss period is typically months 3–6 when therapeutic dosing is reached.

Can you drink alcohol on Ozempic?

There is no absolute contraindication, but alcohol is generally not recommended on Ozempic. Many users report increased sensitivity to alcohol (getting drunk faster), more severe nausea, and worsened GI side effects. Alcohol also adds empty calories that counteract weight loss. If you choose to drink, do so in strict moderation and be aware of your changed tolerance.

What happens if I miss a dose of Ozempic?

If you miss your scheduled dose and it has been 5 days or fewer since the missed dose, inject as soon as you remember. If more than 5 days have passed, skip the missed dose and resume your regular weekly schedule. Never double up to make up for a missed injection.

Does Ozempic cause hair loss?

Hair loss is not listed as a clinical side effect of Ozempic itself, but is commonly reported by users. The likely cause is telogen effluvium — a temporary hair shedding triggered by the stress of rapid weight loss and caloric restriction, not the medication directly. It typically resolves on its own within 3–6 months as the body adjusts.

Is Ozempic the same as semaglutide?

Yes. Ozempic is the brand name; semaglutide is the generic (active ingredient) name. Wegovy is also semaglutide — the same molecule at a higher dose (2.4mg vs. 2.0mg max for Ozempic). There is no generic version of semaglutide approved by the FDA as of 2026.

Medical Disclaimer: The information provided by GLP1Tools is for educational and informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.